News and Trends 31 Oct 2016
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a huge success. Now awaiting US FDA and EMA approval, the results from the latest study…